Skip to main content
logo
Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
30.42
-0.25 (-0.82%)
Nov 3, 2026, 2:05 PM EST - Market open

Pfizer Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Operating Revenue
16,58315,03414,45017,55716,65414,65313,71517,76417,70113,28314,87814,57013,49213,00618,48524,29022,63827,74225,66123,838
Other Revenue
--1-----11---1-1------
Revenue
16,58315,03414,45117,55716,65414,65313,71517,76317,70213,28314,87814,56913,49213,00718,48524,29022,63827,74225,66123,838
Revenue Growth (YoY)
-0.43%2.60%5.37%-1.16%-5.92%10.31%-7.82%21.92%31.20%2.12%-19.51%-40.02%-40.40%-53.11%-27.96%1.90%-5.81%46.79%76.78%108.61%
Cost of Revenue
4,0283,6553,4075,0653,9793,5012,5926,5134,8732,7683,0361,0668,9053,0724,7479,4756,0378,6259,9589,711
Gross Profit
12,55511,37911,04412,49212,67511,15211,12311,25012,82910,51511,84213,5034,5879,93513,73814,81516,60119,11715,70314,127
Selling, General & Admin
3,2793,2572,8403,7353,0853,2942,9104,7443,1143,5593,3484,1283,1123,3343,2763,8532,9353,1942,2182,978
Research & Development
3,0162,7462,4523,3232,4922,4432,1793,1012,5652,6762,4802,7732,6822,6292,4943,6152,6962,8152,3013,447
Amortization of Goodwill & Intangibles
1,1281,1851,1831,2301,2231,2111,2111,3591,3121,3071,3081,2671,1791,1841,1031,131822822835957
Operating Expenses
7,4237,1886,4758,2886,8006,9486,3009,2046,9917,5427,1368,1686,9737,1476,8738,5996,4536,8315,3547,382
Operating Income
5,1324,1914,5694,2045,8754,2044,8232,0465,8382,9734,7065,335-2,3862,7886,8656,21610,14812,28610,3496,745
Interest Expense
--667-668-711-652-654-654-739-783-778-790-688-695-508-318-313-311-293-322-316
Interest & Investment Income
-211197247138229182260116130190872523316480451703014181
Earnings From Equity Investments
--------15040-8815113115668153-51149184164
Currency Exchange Gain (Loss)
-----------164----321-420---95
Other Non Operating Income (Expenses)
-286515361,353181172103-56-21716750-3662291881505741,079206294612
EBT Excluding Unusual Items
4,8464,2504,1345,0935,5423,9514,4541,5115,1042,5324,0685,468-2,1982,9407,2456,76010,51512,37810,5197,291
Merger & Restructuring Charges
-791-1,242-619-847-564-332-887-935-774-1,838-494-2,873-413-621-187-1,242-367-355-303-427
Gain (Loss) on Sale of Investments
-1,833-9-4020175-3702,562446-3421752,299-393135-45180-112-541-699-257
Gain (Loss) on Sale of Assets
--------420---222---6-7-1-
Asset Writedown
--4,325--4,363-260-93-224-2,946--240-109-2,888---264-221-200---86
Legal Settlements
--842-191-302-191-422-142-145-45-169-208-228-71-139-36-55-77-19-79-70
Other Unusual Items
--311-9-971-4-133-38451-3-40-11-6,185-210-13-16-25-228-14-33-156
Pretax Income
3,386-6533,169-1,6423,3343,0442,784-104,715-1033,421-4,129-3,3522,2696,2705,2309,00011,4489,0513,826
Income Tax Expense
134-407461-2-216141-189-421234-134293-795-964-717152303561,5701,172249
Earnings From Continuing Operations
3,252-2462,708-1,6403,5502,9032,9734114,481313,128-3,334-2,3882,3405,5555,0008,6449,8787,8793,577
Earnings From Discontinued Operations
-8-13--25-7-817-5-2612-212-2134-9-186
Net Income to Company
3,252-2382,695-1,6403,5502,9282,9734184,473483,123-3,360-2,3762,3385,5565,0028,6239,9127,8703,391
Minority Interest in Earnings
-10-10-8-8-9-18-6-8-8-7-8-9-6-11-13-8-15-6-62
Net Income
3,242-2482,687-1,6483,5412,9102,9674104,465413,115-3,369-2,3822,3275,5434,9948,6089,9067,8643,393
Net Income to Common
3,242-2482,687-1,6483,5412,9102,9674104,465413,115-3,369-2,3822,3275,5434,9948,6089,9067,8643,393
Net Income Growth (YoY)
-8.44%--9.44%--20.69%6997.56%-4.75%---98.24%-43.80%---76.51%-29.51%47.19%5.67%78.07%61.25%301.06%
Shares Outstanding (Basic)
5,7005,6995,6915,6865,6855,6855,6755,6675,6675,6665,6575,6475,6465,6465,6345,6155,6075,5935,6175,616
Shares Outstanding (Diluted)
5,7515,6995,7315,6865,7145,7065,7105,7035,7055,6965,6975,6475,6465,7135,7275,7435,7185,7125,7585,768
Shares Change (YoY)
0.65%-0.12%0.37%-0.30%0.16%0.18%0.23%0.99%1.04%-0.30%-0.52%-1.67%-1.26%0.02%-0.54%-0.43%-0.12%0.60%1.70%1.87%
EPS (Basic)
0.57-0.040.47-0.290.620.510.520.070.790.010.55-0.60-0.420.410.980.891.541.771.400.60
EPS (Diluted)
0.56-0.040.47-0.290.620.510.520.070.790.010.55-0.60-0.420.410.970.871.511.741.370.59
EPS Growth (YoY)
-9.68%--10.05%--21.31%6973.98%-5.30%---98.23%-43.40%---76.40%-29.10%47.11%5.50%77.42%59.09%289.72%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Free Cash Flow
-3022,1794,5034,001-1,7715,8046,063-2,4183864,1962,646-2,122737,5815,1337,4195,8984,912
Free Cash Flow Per Share
-0.050.380.790.70-0.311.021.06-0.420.070.740.47-0.370.011.320.901.301.020.85
Dividend Per Share
-0.4300.4300.8600.4300.4300.4300.8400.4200.4200.4200.4100.4100.4100.4100.4000.4000.4000.4000.390
Dividend Growth (YoY)
-0%0%2.38%2.38%2.38%2.38%104.88%2.44%2.44%2.44%2.50%2.50%2.50%2.50%2.56%2.56%2.56%2.56%2.63%
Gross Margin
75.71%75.69%76.42%71.15%76.11%76.11%81.10%63.33%72.47%79.16%79.59%92.68%34.00%76.38%74.32%60.99%73.33%68.91%61.19%59.26%
Operating Margin
30.95%27.88%31.62%23.95%35.28%28.69%35.17%11.52%32.98%22.38%31.63%36.62%-17.69%21.44%37.14%25.59%44.83%44.29%40.33%28.29%
Profit Margin
19.55%-1.65%18.59%-9.39%21.26%19.86%21.63%2.31%25.22%0.31%20.94%-23.12%-17.66%17.89%29.99%20.56%38.02%35.71%30.65%14.23%
Free Cash Flow Margin
-2.01%15.08%25.65%24.02%-12.91%32.67%34.25%-18.20%2.59%28.80%19.61%-16.31%0.40%31.21%22.67%26.74%22.98%20.61%
EBITDA
6,7435,8026,1795,8647,5335,8266,4373,8347,5854,7006,4387,001-8314,3568,3347,72111,32413,45511,5278,069
EBITDA Margin
40.66%38.59%42.76%33.40%45.23%39.76%46.93%21.58%42.85%35.38%43.27%48.05%-6.16%33.49%45.08%31.79%50.02%48.50%44.92%33.85%
D&A For EBITDA
1,6111,6111,6101,6601,6581,6221,6141,7881,7471,7271,7321,6661,5551,5681,4691,5051,1761,1691,1781,324
EBIT
5,1324,1914,5694,2045,8754,2044,8232,0465,8382,9734,7065,335-2,3862,7886,8656,21610,14812,28610,3496,745
EBIT Margin
30.95%27.88%31.62%23.95%35.28%28.69%35.17%11.52%32.98%22.38%31.63%36.62%-17.68%21.44%37.14%25.59%44.83%44.29%40.33%28.29%
Effective Tax Rate
3.96%-14.55%--4.63%--4.96%-8.57%---11.40%4.40%3.96%13.71%12.95%6.51%
Revenue as Reported
16,58315,03414,45117,55716,65414,65313,71517,76317,70213,28314,87914,56913,49113,00718,486100,330----
SEC Filings: 10-K · 10-Q